These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34060442)

  • 21. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2.
    Behmard E; Soleymani B; Najafi A; Barzegari E
    Sci Rep; 2020 Nov; 10(1):20864. PubMed ID: 33257716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
    Poran A; Harjanto D; Malloy M; Arieta CM; Rothenberg DA; Lenkala D; van Buuren MM; Addona TA; Rooney MS; Srinivasan L; Gaynor RB
    Genome Med; 2020 Aug; 12(1):70. PubMed ID: 32791978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach.
    Mallavarpu Ambrose J; Priya Veeraraghavan V; Kullappan M; Chellapandiyan P; Krishna Mohan S; Manivel VA
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34066389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of multi-epitope peptide-based vaccines against SARS-CoV-2.
    Lim HX; Lim J; Jazayeri SD; Poppema S; Poh CL
    Biomed J; 2021 Mar; 44(1):18-30. PubMed ID: 33727051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches.
    Yu M; Zhu Y; Li Y; Chen Z; Li Z; Wang J; Li Z; Zhang F; Ding J
    Front Immunol; 2022; 13():884433. PubMed ID: 35603198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
    Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
    Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).
    Anand R; Biswal S; Bhatt R; Tiwary BN
    PeerJ; 2020; 8():e9855. PubMed ID: 33062414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.
    Oyarzun P; Kashyap M; Fica V; Salas-Burgos A; Gonzalez-Galarza FF; McCabe A; Jones AR; Middleton D; Kobe B
    Front Immunol; 2021; 12():598778. PubMed ID: 33717077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    Adam KM
    Trop Dis Travel Med Vaccines; 2021 Jul; 7(1):22. PubMed ID: 34238372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
    Noorimotlagh Z; Karami C; Mirzaee SA; Kaffashian M; Mami S; Azizi M
    Int Immunopharmacol; 2020 Sep; 86():106738. PubMed ID: 32683296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
    Schmidt KG; Nganou-Makamdop K; Tenbusch M; El Kenz B; Maier C; Lapuente D; Überla K; Spriewald B; Bergmann S; Harrer EG; Harrer T
    Front Immunol; 2021; 12():627568. PubMed ID: 33995351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.
    Baruah V; Bose S
    J Med Virol; 2020 May; 92(5):495-500. PubMed ID: 32022276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an
    Kumar A; Kumar P; Saumya KU; Kapuganti SK; Bhardwaj T; Giri R
    Expert Rev Vaccines; 2020 Sep; 19(9):887-898. PubMed ID: 32815406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.
    Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB
    Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrative immunoinformatics paradigm for predicting potential B-cell and T-cell epitopes as viable candidates for subunit vaccine design against COVID-19 virulence.
    Sarma VR; Olotu FA; Soliman MES
    Biomed J; 2021 Aug; 44(4):447-460. PubMed ID: 34489196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoinformatics prediction of OMP2b and BCSP31 for designing multi-epitope vaccine against Brucella.
    Li Z; Zhang F; Zhang C; Wang C; Lu P; Zhao X; Hao L; Ding J
    Mol Immunol; 2019 Oct; 114():651-660. PubMed ID: 31557626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach.
    Hisham Y; Ashhab Y; Hwang SH; Kim DE
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prediction and analysis of B cell and T cell epitopes in the spike protein of SARS-CoV-2 by bioinformatics].
    Tao J; Li S; Yang J; Zhang T; Lyu Y; Zhao W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jan; 39(1):49-56. PubMed ID: 36631015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework.
    Kumar N; Admane N; Kumari A; Sood D; Grover S; Prajapati VK; Chandra R; Grover A
    Sci Rep; 2021 Apr; 11(1):7653. PubMed ID: 33828130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
    Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O
    Front Immunol; 2020; 11():2008. PubMed ID: 33013857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.